Table 1 Baseline characteristics and medications during study period (n = 37 acute ischaemic stroke patients at entry)
Mean age (SD) (years) | 69.0 (13.1) |
Male | 24 (65%) |
Caucasian | 37 (100%) |
Body mass index* (kg/m2) | 26 (18,41) |
Vital signs at presentation | Â |
   Systolic blood pressure* (mm Hg) | 152 (60, 232) |
   Diastolic blood pressure* (mm Hg) | 83 (40, 146) |
   Aural temperature* (°C) | 36.4 (34.8, 38.0) |
Conventional vascular risk factors | Â |
   Current or former smoker | 26 (70%) |
   Smoking history unknown | 1 (3%) |
   Previous stroke | 7 (19%) |
   Hypertension | 24 (65%) |
   Atrial fibrillation | 8 (22%) |
   Diabetes mellitus | 3 (8%) |
   Ischaemic heart disease | 8 (22%) |
Medications preceding or during study period | Â |
   Paracetamol during first week | 21 (57%) |
   Paracetamol during first week unknown | 1 (3%) |
   Statins | 21 (57%) |
   Antiplatelet agents | 33 (89%) |
   Warfarin | 4 (11%) |
   ACE-I or A-II receptor antagonist | 10 (27%) |